Summary

Peptide Cosmetic API Research Report by Application (Anti-Aging & Wrinkle Reduction, Skin Repair & Regeneration, Moisturizing & Hydration, Whitening & Brightening, Hair Care, Anti-Inflammatory & Soothing), by Source (Plant-Derived Peptides, Animal-Derived Peptides, Bioengineered Peptides, Chemically Synthesized), by End-Use Industry (Skincare, Haircare, Injectable Cosmetics, Others), by Region (North America, Europe, APAC, South America, MEA) Forecast till 2035

Market Overview
Global peptide cosmetic API market generated USD 921.3 million in revenue in 2024 and expected to achieve USD 2,968.4 million by 2035 at a CAGR of 11.2%.
Global peptide cosmetic API market is being significantly driven by the rising demand for natural and organic cosmetic products, as consumers increasingly seek safer and more skin-friendly alternatives. Technological advancements in peptide synthesis have further propelled market growth, enabling the development of more stable and effective formulations. Additionally, the growing trend toward personalized skincare has heightened the appeal of peptides, which can be tailored to target specific skin concerns. Ongoing research highlighting the dermatological benefits of peptides continues to support their widespread adoption in cosmetic applications.
However, the market faces several restraints, including the high cost of peptide synthesis and formulation, challenges in stability and effective delivery, and stringent regulatory requirements that often lead to approval delays. Furthermore, the presence of alternative active ingredients adds to competitive pressures.
Despite these challenges, the global market presents strong opportunities, particularly in areas like bioengineered peptides for clean beauty, AI-powered skincare personalization, men's grooming with anti-aging solutions, multi-step skincare innovations, and innovations in peptide research.

Market Segmentations
By application category, the Global peptide cosmetic API market is divided into anti-aging & wrinkle reduction, skin repair & regeneration, moisturizing & hydration, whitening & brightening, hair care, anti-inflammatory & soothing.
Based on the source type, the global market is included plant-derived peptides, animal-derived peptides, bioengineered peptides, chemically synthesized.
Skincare, haircare, injectable cosmetics, and others are the part of end-use type of the global peptide cosmetic API market.

Regional Insights
North America dominates global peptide cosmetic API market owing to strong consumer awareness, a solid base of established cosmetic companies, and rising demand for advanced anti-aging and functional skincare products. The presence of leading R&D centers and an inclination toward premium, scientifically backed formulas further supports market leadership.
Europe is close behind, driven by the clean beauty movement, stringent safety regulations, and a well-developed anti-aging segment in markets like France, the UK, and Germany.
Asia-Pacific exhibits the fastest expansion, fueled by increasing skincare awareness, influence from K-beauty and J-beauty trends, and accelerating urbanization in key nations like China, Japan, and South Korea. Consumers here are drawn to multifunctional, innovative cosmetics.
Latin America, especially Brazil, is steadily rising due to growing interest in natural and age-defying formulations.
The Middle East & Africa region is showing gradual development, primarily supported by urban areas and a rise in disposable income levels.

Major Players
Major players of global peptide cosmetic API research report are Ashland Global Holdings, Symrise AG, Spec-Chem Industry Inc, Chemisches Laboratorium Dr. Kurt Richter GmbH, DSM-Firmenich, Provital Group, Bachem, Lipotrue Science, Croda, Caregen, BASF SE, Evonik Industries AG, Givaudan Active Beauty, Ambiopharm, Lipotec, USV Private Limited, Active Peptide Company, Seiwa Kasei Co. Ltd., RS Synthesis, BCN Peptides.

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1 EXECUTIVE SUMMARY .......................................... 21
2 MARKET INTRODUCTION ...................................... 23
2.1 DEFINITION .................... 23
2.2 SCOPE OF THE STUDY ....................................................................... 23
2.3 RESEARCH OBJECTIVE ..................................................................... 23
2.4 MARKET STRUCTURE ....................................................................... 24
3 RESEARCH METHODOLOGY ................................. 26
3.1 OVERVIEW ...................... 26
3.2 DATA FLOW .................... 28
3.2.1 DATA MINING PROCESS ................................................................ 28
3.3 PURCHASED DATABASE: .................................................................. 29
3.4 SECONDARY SOURCES: ..................................................................... 30
3.4.1 SECONDARY RESEARCH DATA FLOW: ................................................ 31
3.5 PRIMARY RESEARCH: ........................................................................ 32
3.5.1 PRIMARY RESEARCH DATA FLOW: ................................................ 33
3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED .................. 34
3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE ....................................... 34
3.6 APPROACHES FOR MARKET END USER ESTIMATION: ........ 35
3.6.1 REVENUE ANALYSIS APPROACH ..................................................... 35
3.6.2 DATA FORECASTING ...................................................................... 36
3.6.3 DATA FORECASTING TECHNIQUE ..................................................... 36
3.7 DATA MODELING .......... 37
3.7.1 MICROECONOMIC FACTOR ANALYSIS: ................................................ 37
3.7.2 DATA MODELING: ........................................................................ 38
3.8 TEAMS AND ANALYST CONTRIBUTION .................................... 39
4 MARKET DYNAMICS ............................................... 41
4.1 INTRODUCTION ............. 41
4.2 DRIVERS ........................... 42
4.2.1 INCREASING DEMAND FOR NATURAL AND ORGANIC COSMETICS ............. 42
4.2.2 TECHNOLOGICAL ADVANCEMENTS IN PEPTIDE SYNTHESIS ................... 42
4.2.3 GROWING PREFERENCE FOR PERSONALIZED SKINCARE SOLUTIONS ........... 43
4.2.4 EXPANDING RESEARCH ON PEPTIDE BENEFITS IN DERMATOLOGY ........... 43
4.3 RESTRAINTS .................. 43
4.3.1 HIGH COST OF PEPTIDE SYNTHESIS AND FORMULATION ....................... 43
4.3.2 STABILITY AND DELIVERY CHALLENGES .............................................. 44
4.3.3 REGULATORY COMPLEXITIES AND APPROVAL DELAYS ........................... 44
4.3.4 COMPETITION FROM ALTERNATIVE ACTIVE INGREDIENTS........................ 44
4.4 OPPORTUNITY ............... 45
4.4.1 BIOENGINEERED PEPTIDES IN CLEAN BEAUTY ................................... 45
4.4.2 AI-DRIVEN PERSONALIZED SKINCARE ............................................... 45
4.4.3 PEPTIDES IN MULTI-STEP SKINCARE REGIMENS................................. 45
4.4.4 MEN'S GROOMING AND ANTI-AGING SOLUTIONS ................................. 46
4.4.5 INNOVATIONS IN PEPTIDE RESEARCH ............................................... 46
4.5 IMPACT ANALYSIS OF COVID – 19 ................................................ 47
4.5.1 IMPACT 0N OVERALL HEALTHCARE. .............................................. 47
4.5.2 ECONOMIC IMPACT. ................................................................ 47
4.5.3 IMPACT ON GLOBAL PEPTIDE COSMETIC API MARKET MARKET. ... 48
4.5.4 IMPACT ON SUPPLY CHAIN OF PEPTIDE COSMETIC API MARKET..... 48
4.5.5 PRICE VARIATION OF KEY RAW MATERIALS. ............................ 48
4.5.6 PRODUCTION SHUTDOWN. ...................................................... 49
4.5.7 CASH FLOW CONSTRAINTS. .................................................... 49
4.5.8 IMPACT ON IMPORT/EXPORT. ................................................. 49
4.5.9 IMPACT ON MARKET DEMAND OF PEPTIDE COSMETIC API MARKET. ...................................................................... 50
4.5.10 IMPACT DUE TO RESTRICTIONS/LOCKDOWN. ........................... 50
4.5.11 CONSUMER SENTIMENTS. ....................................................... 50
4.5.12 IMPACT ON PRICING OF PEPTIDE COSMETIC API MARKET. ............ 51
5 MARKET FACTOR ANALYSIS ................................. 52
5.1 SUPPLY CHAIN ANALYSIS .............................................................. 52
5.1.1 RAW MATERIAL PROCUREMENT .............................................. 53
5.1.2 MANUFACTURING & SYNTHESIS .............................................. 53
5.1.3 PACKAGING AND STORAGE ..................................................... 54
5.1.4 DISTRIBUTION & LOGISTICS ..................................................... 54
5.1.5 END-USERS & CONSUMER DELIVERY ........................................ 54
5.2 PORTER’S FIVE FORCES MODEL .................................................... 55
5.2.1 BARGAINING POWER OF SUPPLIERS .................................................. 55
5.2.2 BARGAINING POWER OF BUYERS ..................................................... 56
5.2.3 THREAT OF NEW ENTRANTS ............................................................ 56
5.2.4 THREAT OF SUBSTITUTES ............................................................... 56
5.2.5 INTENSITY OF RIVALRY ................................................................... 57
6 PEPTIDE COSMETIC API MARKET, BY APPLICATION .............................................................. 59
6.1 INTRODUCTION ............. 59
6.2 ANTI-AGING & WRINKLE REDUCTION ........................................ 59
6.3 SKIN REPAIR & REGENERATION ................................................... 60
6.4 MOISTURIZING & HYDRATION ....................................................... 60
6.5 WHITENING & BRIGHTENING ......................................................... 60
6.6 HAIR CARE ...................... 61
6.7 ANTI-INFLAMMATORY & SOOTHING .......................................... 61
7 PEPTIDE COSMETIC API MARKET, BY SOURCE . 62
7.1 INTRODUCTION ............. 62
7.2 PLANT-DERIVED PEPTIDES ............................................................ 62
7.3 ANIMAL-DERIVED PEPTIDES ......................................................... 62
7.4 BIOENGINEERED PEPTIDES ............................................................. 63
7.5 CHEMICALLY SYNTHESIZED .......................................................... 63
8 PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY.................................................... 64
8.1 INTRODUCTION ............. 64
8.2 SKINCARE ....................... 64
8.3 HAIRCARE ....................... 64
8.4 INJECTABLE COSMETICS ................................................................. 65
8.5 OTHERS ............................ 65
9 PEPTIDE COSMETIC API MARKET, BY REGION .. 66
9.1 OVERVIEW ...................... 66
9.2 NORTH AMERICA ......... 67
9.2.1 US.................... 68
9.2.2 CANADA ............ 69
9.3 EUROPE ............................ 70
9.3.1 GERMANY .......... 71
9.3.2 UK ................... 73
9.3.3 FRANCE ........... 74
9.3.4 RUSSIA ............ 75
9.3.5 ITALY ............... 76
9.3.6 SPAIN .............. 77
9.3.7 REST OF EUROPE ..................................................................... 78
9.4 APAC ................................. 79
9.4.1 CHINA ............... 80
9.4.2 INDIA ............... 81
9.4.3 JAPAN ............. 82
9.4.4 SOUTH KOREA .. 83
9.4.5 MALAYSIA ....... 84
9.4.6 THAILAND ........ 85
9.4.7 INDONESIA ....... 86
9.4.8 REST OF APAC ........................................................................ 87
9.5 SOUTH AMERICA ......... 88
9.5.1 BRAZIL ............... 89
9.5.2 MEXICO ........... 91
9.5.3 ARGENTINA ..... 92
9.5.4 REST OF SOUTH AMERICA ....................................................... 93
9.6 MEA ................................... 94
9.6.1 GCC COUNTRIES .. 95
9.6.2 SOUTH AFRICA ..... 96
9.6.3 REST OF MEA ..... 97
10 COMPETITIVE LANDSCAPE ................................... 99
10.1 INTRODUCTION ............. 99
10.2 MARKET SHARE ANALYSIS, 2023 ................................................ 99
10.3 COMPETITOR DASHBOARD.............................................................. 101
11 COMPANY PROFILES ............................................. 102
11.1 DSM-FIRMENICH .......... 102
11.1.1 COMPANY OVERVIEW .............................................................. 102
11.1.2 FINANCIAL OVERVIEW.............................................................. 103
11.1.3 TYPES OFFERED ...................................................................... 103
11.1.4 PATENT DETAILS ... 104
11.1.5 PRODUCTION CAPACITY ................................................................ 104
11.1.6 SALES VOLUME ... 104
11.1.7 PRICING ANALYSIS ....................................................................... 105
11.1.8 SWOT ANALYSIS ..................................................................... 105
11.1.9 KEY STRATEGY ..... 106
11.2 BACHEM .......................... 107
11.2.1 COMPANY OVERVIEW .............................................................. 107
11.2.2 FINANCIAL OVERVIEW.............................................................. 108
11.2.3 TYPES OFFERED ...................................................................... 108
11.2.4 PATENT DETAILS ... 109
11.2.5 PRODUCTION CAPACITY ................................................................ 109
11.2.6 SALES VOLUME ... 109
11.2.7 PRICING ANALYSIS ....................................................................... 109
11.2.8 SWOT ANALYSIS ..................................................................... 110
11.2.9 KEY STRATEGY ..... 110
11.3 LIPOTRUE SCIENCE ..... 111
11.3.1 COMPANY OVERVIEW .............................................................. 111
11.3.2 TYPES OFFERED ...................................................................... 111
11.3.3 PATENT DETAILS ... 111
11.3.4 PRODUCTION CAPACITY ................................................................ 112
11.3.5 SALES VOLUME ... 112
11.3.6 PRICING ANALYSIS ....................................................................... 112
11.3.7 SWOT ANALYSIS ..................................................................... 113
11.3.8 KEY STRATEGY ..... 113
11.4 CRODA ............................... 114
11.4.1 COMPANY OVERVIEW .............................................................. 114
11.4.2 FINANCIAL OVERVIEW.............................................................. 115
11.4.3 TYPES OFFERED ...................................................................... 115
11.4.4 PATENT DETAILS ... 116
11.4.5 PRODUCTION CAPACITY ................................................................ 116
11.4.6 SALES VOLUME ... 116
11.4.7 PRICING ANALYSIS ....................................................................... 116
11.4.8 SWOT ANALYSIS ..................................................................... 117
11.4.9 KEY STRATEGY ..... 117
11.5 CAREGEN ......................... 118
11.5.1 COMPANY OVERVIEW .............................................................. 118
11.5.2 TYPES OFFERED ...................................................................... 118
11.5.3 PATENT DETAILS ... 118
11.5.4 PRODUCTION CAPACITY ................................................................ 119
11.5.5 SALES VOLUME ... 119
11.5.6 PRICING ANALYSIS ....................................................................... 119
11.5.7 SWOT ANALYSIS ..................................................................... 120
11.5.8 KEY STRATEGY ..... 120
11.6 BASF SE ............................ 121
11.6.1 COMPANY OVERVIEW .............................................................. 121
11.6.2 FINANCIAL OVERVIEW.............................................................. 121
11.6.3 TYPES OFFERED ...................................................................... 122
11.6.4 PATENT DETAILS ... 122
11.6.5 PRODUCTION CAPACITY ................................................................ 122
11.6.6 SALES VOLUME ... 123
11.6.7 PRICING ANALYSIS ....................................................................... 123
11.6.8 SWOT ANALYSIS ..................................................................... 123
11.6.9 KEY STRATEGY ..... 124
11.7 EVONIK INDUSTRIES AG .................................................................. 125
11.7.1 COMPANY OVERVIEW ............................................................. 125
11.7.2 FINANCIAL OVERVIEW.............................................................. 126
11.7.3 TYPES OFFERED ...................................................................... 126
11.7.4 PATENT DETAILS ... 127
11.7.5 PRODUCTION CAPACITY ................................................................ 127
11.7.6 SALES VOLUME ... 127
11.7.7 PRICING ANALYSIS ....................................................................... 127
11.7.8 SWOT ANALYSIS ..................................................................... 128
11.7.9 KEY STRATEGY ..... 128
11.8 GIVAUDAN ACTIVE BEAUTY .......................................................... 129
11.8.1 COMPANY OVERVIEW ............................................................. 129
11.8.2 FINANCIAL OVERVIEW.............................................................. 129
11.8.3 TYPES OFFERED ...................................................................... 130
11.8.4 PATENT DETAILS ... 130
11.8.5 PRODUCTION CAPACITY ................................................................ 130
11.8.6 SALES VOLUME ... 130
11.8.7 PRICING ANALYSIS ....................................................................... 131
11.8.8 SWOT ANALYSIS ..................................................................... 131
11.8.9 KEY STRATEGY ..... 132
11.9 ASHLAND GLOBAL HOLDINGS ........................................................ 133
11.9.1 COMPANY OVERVIEW .............................................................. 133
11.9.2 FINANCIAL OVERVIEW.............................................................. 133
11.9.3 TYPES OFFERED ...................................................................... 134
11.9.4 PATENT DETAILS ... 134
11.9.5 PRODUCTION CAPACITY ................................................................ 134
11.9.6 SALES VOLUME ... 134
11.9.7 PRICING ANALYSIS ....................................................................... 135
11.9.8 SWOT ANALYSIS ..................................................................... 135
11.9.9 KEY STRATEGY ..... 135
11.10 SYMRISE AG ................... 136
11.10.1 COMPANY OVERVIEW .............................................................. 136
11.10.2 FINANCIAL OVERVIEW.............................................................. 136
11.10.3 TYPES OFFERED ...................................................................... 137
11.10.4 PATENT DETAILS ... 137
11.10.5 PRODUCTION CAPACITY ................................................................ 137
11.10.6 SALES VOLUME ... 137
11.10.7 PRICING ANALYSIS ....................................................................... 137
11.10.8 SWOT ANALYSIS ..................................................................... 138
11.10.9 KEY STRATEGY ..... 138
11.11 PROVITAL GROUP ........ 139
11.11.1 COMPANY OVERVIEW .............................................................. 139
11.11.2 TYPES OFFERED ...................................................................... 139
11.11.3 PATENT DETAILS ... 139
11.11.4 PRODUCTION CAPACITY ................................................................ 140
11.11.5 SALES VOLUME ... 140
11.11.6 PRICING ANALYSIS ....................................................................... 140
11.11.7 SWOT ANALYSIS ..................................................................... 141
11.11.8 KEY STRATEGY ..... 141
11.12 SPEC-CHEM INDUSTRY INC ............................................................ 142
11.12.1 COMPANY OVERVIEW .............................................................. 142
11.12.2 TYPES OFFERED ...................................................................... 142
11.12.3 PATENT DETAILS ... 142
11.12.4 PRODUCTION CAPACITY ................................................................ 143
11.12.5 SALES VOLUME ... 143
11.12.6 PRICING ANALYSIS ....................................................................... 143
11.12.7 SWOT ANALYSIS ..................................................................... 144
11.12.8 KEY STRATEGY ..... 144
11.13 AMBIOPHARM ............... 145
11.13.1 COMPANY OVERVIEW .............................................................. 145
11.13.2 TYPES OFFERED ...................................................................... 145
11.13.3 PATENT DETAILS ... 145
11.13.4 PRODUCTION CAPACITY ................................................................ 146
11.13.5 SALES VOLUME ... 146
11.13.6 PRICING ANALYSIS ....................................................................... 146
11.13.7 SWOT ANALYSIS ..................................................................... 147
11.13.8 KEY STRATEGY ..... 147
11.14 LIPOTEC ........................... 148
11.14.1 COMPANY OVERVIEW ............................................................. 148
11.14.2 TYPES OFFERED ...................................................................... 148
11.14.3 PATENT DETAILS ... 148
11.14.4 PRODUCTION CAPACITY ................................................................ 149
11.14.5 SALES VOLUME ... 149
11.14.6 PRICING ANALYSIS ....................................................................... 149
11.14.7 SWOT ANALYSIS ..................................................................... 150
11.14.8 KEY STRATEGY ..... 150
11.15 USV PRIVATE LIMITED ..................................................................... 151
11.15.1 COMPANY OVERVIEW ............................................................. 151
11.15.2 TYPES OFFERED ...................................................................... 151
11.15.3 PATENT DETAILS ... 151
11.15.4 PRODUCTION CAPACITY ................................................................ 152
11.15.5 SALES VOLUME ... 152
11.15.6 PRICING ANALYSIS ....................................................................... 152
11.15.7 SWOT ANALYSIS ..................................................................... 153
11.15.8 KEY STRATEGY ..... 153
11.16 CHEMISCHES LABORATORIUM DR. KURT RICHTER GMBH (CLR) ........................................................... 154
11.16.1 COMPANY OVERVIEW .............................................................. 154
11.16.2 TYPES OFFERED ...................................................................... 154
11.16.3 PATENT DETAILS ... 154
11.16.4 PRODUCTION CAPACITY ................................................................ 155
11.16.5 SALES VOLUME ... 155
11.16.6 PRICING ANALYSIS ....................................................................... 155
11.16.7 SWOT ANALYSIS ..................................................................... 156
11.16.8 KEY STRATEGY ..... 156
11.17 ACTIVE PEPTIDE COMPANY ........................................................... 157
11.17.1 COMPANY OVERVIEW .............................................................. 157
11.17.2 TYPES OFFERED ...................................................................... 157
11.17.3 PATENT DETAILS ... 158
11.17.4 PRODUCTION CAPACITY ................................................................ 158
11.17.5 SALES VOLUME ... 158
11.17.6 PRICING ANALYSIS ....................................................................... 158
11.17.7 SWOT ANALYSIS ..................................................................... 159
11.17.8 KEY STRATEGY ..... 159
11.18 SEIWA KASEI CO., LTD ....................................................................... 160
11.18.1 COMPANY OVERVIEW ............................................................. 160
11.18.2 TYPES OFFERED ...................................................................... 160
11.18.3 PATENT DETAILS ... 160
11.18.4 PRODUCTION CAPACITY ................................................................ 161
11.18.5 SALES VOLUME ... 161
11.18.6 PRICING ANALYSIS ....................................................................... 161
11.18.7 SWOT ANALYSIS ..................................................................... 162
11.18.8 KEY STRATEGY ..... 162
11.19 RS SYNTHESIS ............... 163
11.19.1 COMPANY OVERVIEW .............................................................. 163
11.19.2 TYPES OFFERED ...................................................................... 163
11.19.3 PATENT DETAILS ... 163
11.19.4 PRODUCTION CAPACITY ................................................................ 164
11.19.5 SALES VOLUME ... 164
11.19.6 PRICING ANALYSIS ....................................................................... 164
11.19.7 SWOT ANALYSIS ..................................................................... 165
11.19.8 KEY STRATEGY ..... 165
11.20 BCN PEPTIDES ............... 166
11.20.1 COMPANY OVERVIEW .............................................................. 166
11.20.2 TYPES OFFERED ...................................................................... 166
11.20.3 PATENT DETAILS ... 166
11.20.4 PRODUCTION CAPACITY ................................................................ 167
11.20.5 SALES VOLUME ... 167
11.20.6 PRICING ANALYSIS ....................................................................... 167
11.20.7 SWOT ANALYSIS ..................................................................... 168
11.20.8 KEY STRATEGY ............................................................................ 168